Finance

Lists
ELV:NYSE
Elevance Health Inc
၄၂၈.၀၉ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၄, GMT-၄ ၁၆:၀၀:၀၂  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELV...
Mkt. cap
ဋေ ၉.၂၂ ထ
Avg. vol.
၁.၂၆ သန်း
Volume
၃၅၂.၀၀
52-wk high
၄၃၆.၂၄ US$
52-wk low
၂၇၄.၈၄ US$
Beta
၀.၇၀
Shares outstanding
၂၁.၆၉ ကုဋေ
No. of employees
၁ သိန်း
Mkt. cap
ဋေ ၉.၂၂ ထ
Avg. vol.
၁.၂၆ သန်း
Volume
၃၅၂.၀၀
52-wk high
၄၃၆.၂၄ US$
52-wk low
၂၇၄.၈၄ US$
Beta
၀.၇၀
Shares outstanding
၂၁.၆၉ ကုဋေ
No. of employees
၁ သိန်း
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၃ နာရီ
Guggenheim raises target for Elevance Health stock to USD 460
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Privia Health Group (PRVA) Renews Anthem Deal, Is The Stock Still Undervalued?
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁၉ နာရီ
Centene's Gold Card Push Could Ease Costs - But Will Savings Follow?
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Elevance Health options signal 6.8% move on Oct. 21 earnings By Investing.com
Profile
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
About Elevance Health Inc
CEOGail Koziara Boudreaux
Employees၉.၆၆ သောင်း
Founded၁၉၄၄
Headquartersအင်ဒီယားနားပိုလီးစ်, အင်ဒီယားနားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth care provider
Analyst ratings
Based on 14 analysts giving stock ratings to ELV in the past 3 months
Buy
Buy
9
Hold
5
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for ELV in the last 3 months.
Highest
Current ၄၂၈.၀၉ US$
၄၈၈.၀၀ US$ (+၁၃.၉၉%)
Average
၄၄၈.၉၂ US$ (+၄.၈၇%)
Lowest
၃၉၃.၀၀ US$ (-၈.၂၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Cassorla
Guggenheim
Buy
Reiterated
၄၆၀.၀၀ US$
+၇.၅%
10/12/2026
Andrew Mok CFA
Barclays
Buy
Maintained
၄၆၉.၀၀ US$
+၉.၆%
10/07/2026
Ben Hendrix
RBC Capital
Hold
Maintained
၄၂၄.၀၀ US$
-၁%
10/07/2026
Lance Wilkes
Bernstein
Buy
Maintained
၄၈၈.၀၀ US$
+၁၄%
10/05/2026
A.J. Rice
UBS
Buy
Maintained
၄၆၀.၀၀ US$
+၇.၅%
09/18/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
၄၇၃.၀၀ US$
+၁၀.၅%
09/15/2026
Kevin Fischbeck
Bank of America Securities
Buy
Maintained
၄၈၀.၀၀ US$
+၁၂.၁%
09/11/2026
David Toung
Argus Research
Hold
Maintained
-
-
08/20/2026
Whit Mayo
Leerink Partners
Hold
Reiterated
၃၉၅.၀၀ US$
-၇.၇%
07/17/2026
Ryan Langston
TD Cowen
Buy
Reiterated
၄၆၅.၀၀ US$
+၈.၆%
07/17/2026
David Windley
Jefferies
Buy
Maintained
၄၅၀.၀၀ US$
+၅.၁%
07/16/2026
Scott Fidel
Goldman Sachs
Hold
Maintained
၃၉၅.၀၀ US$
-၇.၇%
07/15/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
၄၀၄.၀၀ US$
-၅.၆%
07/17/2026
Michael Ha
Robert W. Baird
Hold
Maintained
၃၉၃.၀၀ US$
-၈.၂%
07/16/2026
Amit Daryanani
Evercore ISI
Hold
Maintained
-
-
07/15/2026
David S Macdonald
Truist Financial
Buy
Reiterated
၄၇၅.၀၀ US$
+၁၁%
07/16/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
၄၇၀.၀၀ US$
+၉.၈%
07/13/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
၄၅၀.၀၀ US$
+၅.၁%
07/07/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
၄၇၆.၀၀ US$
+၁၁.၂%
06/08/2026
George Hill
Deutsche Bank
Buy
Upgraded
၄၉၈.၀၀ US$
+၁၆.၃%
05/20/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Upgraded
၃၆၀.၀၀ US$
-၁၅.၉%
05/19/2026
Next call ၆ ရက်အတွင်း
အောက် ၂၁ ဗုဒ္ဓဟူး, ၁၄:၃၀
Fiscal period
Q3 2026
- / ၄.၆၉ US$
Revenue / Est. (USD)
- / ဋေ ၄.၉၂ ထ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၅.၀၇ ထ
ဋေ ၄.၉၇ ထ
ဋေ ၅.၀၂ ထ
ဋေ ၅.၀၅ ထ
Cost of goods sold
ဋေ ၃.၈၁ ထ
ဋေ ၃.၈၁ ထ
ဋေ ၃.၅၆ ထ
ဋေ ၃.၇၀ ထ
Cost of revenue
ဋေ ၃.၈၁ ထ
ဋေ ၃.၈၁ ထ
ဋေ ၃.၅၆ ထ
ဋေ ၃.၇၀ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၀၇ ထ
ဋေ ၁.၀၈ ထ
ဋေ ၁.၁၈ ထ
ဋေ ၁.၁၀ ထ
Operating expense
ဋေ ၁.၀၈ ထ
ဋေ ၁.၀၉ ထ
ဋေ ၁.၁၉ ထ
ဋေ ၁.၁၁ ထ
Total operating expenses
ဋေ ၄.၉၀ ထ
ဋေ ၄.၉၀ ထ
ဋေ ၄.၇၅ ထ
ဋေ ၄.၈၂ ထ
Operating income
၁၇၅.၇၀ ဋေ
၇၆.၆၀ ကုဋေ
၂၆၆.၁၀ ဋေ
၂၃၀.၁၀ ဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၁၄၀.၆၀ ဋေ
၂၁.၅၀ ကုဋေ
၂၃၀.၄၀ ဋေ
၁၉၃.၇၀ ဋေ
EBT excluding unusual items
၁၄၀.၆၀ ဋေ
၃၉.၉၀ ကုဋေ
၂၃၀.၄၀ ဋေ
၁၉၃.၇၀ ဋေ
Income tax expense
၂၁.၉၀ ကုဋေ
-၃၃.၁၀ ကုဋေ
၅၄.၄၀ ကုဋေ
၄၈.၃၀ ကုဋေ
Effective tax rate
၁၅.၅၈%
-၁၅၃.၉၅%
၂၃.၆၁%
၂၄.၉၄%
Other operating expenses
-
-
-
-
Net income
၁၁၈.၉၀ ဋေ
၅၄.၇၀ ကုဋေ
၁၇၆.၄၀ ဋေ
၁၄၆.၃၀ ဋေ
Net profit margin
၂.၃၄%
၁.၁၀%
၃.၅၂%
၂.၉၀%
Earnings per share
၆.၀၃
၃.၃၃
၁၂.၅၈
၇.၄၅
Interest and investment income
-
-
-
-
Interest expense
-၃၅.၁၀ ကုဋေ
-၃၆.၇၀ ကုဋေ
-၃၅.၇၀ ကုဋေ
-၃၆.၄၀ ကုဋေ
Net interest expenses
-၃၅.၁၀ ကုဋေ
-၃၆.၇၀ ကုဋေ
-၃၅.၇၀ ကုဋေ
-၃၆.၄၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၂၁၄.၄၀ ဋေ
၁၁၇.၂၀ ဋေ
၃၀၁.၅၀ ဋေ
၂၆၆.၇၀ ဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ